{"id":56425,"date":"2025-04-09T15:53:00","date_gmt":"2025-04-09T15:53:00","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/"},"modified":"2025-04-09T15:53:00","modified_gmt":"2025-04-09T15:53:00","slug":"investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/","title":{"rendered":"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-93872e3fb977470f5f06bd6bcd0bda4d wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why This Topic Matters in Pharmaceutical Today<\/a><\/p><p class=\"menu-lewe wp-elements-aba67a0dc810dfcfd69b5b056092d23d wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Understanding the Concept and Its Role in Pharmaceutical<\/a><\/p><p class=\"menu-lewe wp-elements-618228931ba90aa8a1c00bd371da620e wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key Benefits for Pharmaceutical Companies<\/a><\/p><p class=\"menu-lewe wp-elements-179dc25b371c15d03da7ddf32525906f wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">How to Implement the Concept Using KanBo<\/a><\/p><p class=\"menu-lewe wp-elements-6d6cfcdcfe80e729853cf55ca8bdf799 wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Measuring Impact with Pharmaceutical-Relevant Metrics<\/a><\/p><p class=\"menu-lewe wp-elements-35e3a5d7dadc1861e4289edcfe9667d8 wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Challenges and How to Overcome Them in Pharmaceutical<\/a><\/p><p class=\"menu-lewe wp-elements-4c19bedb8140e766ecd467fdeba37b0d wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Quick-Start Guide with KanBo for Pharmaceutical Teams<\/a><\/p><p class=\"menu-lewe wp-elements-c5a87d92945819030f19e88b32a0c137 wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Glossary and terms<\/a><\/p><p class=\"menu-lewe wp-elements-33a8bfb0add1a295e32a1b015be167cc wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why This Topic Matters in Pharmaceutical Today<\/h2><p class=\"tekst-para wp-block-paragraph\">Introduction to Investigational New Drug (IND): A Pillar of Pharmaceutical Innovation<\/p><p class=\"tekst-para wp-block-paragraph\">In the rapidly evolving realm of pharmaceuticals, the Investigational New Drug (IND) application stands as a pivotal element in the drug development pipeline. Its relevance and importance are underscored by the burgeoning demand for innovative therapies and the dynamic landscape of global healthcare needs. The IND is not merely a regulatory requirement; it acts as a catalyst for transforming scientific discoveries into viable medical therapies, thereby shaping the future of healthcare.<\/p><p class=\"tekst-para wp-block-paragraph\">Key Features and Benefits of IND:<\/p><p class=\"tekst-para wp-block-paragraph\">- Facilitating Innovation: The IND process enables pharmaceutical companies to bring novel drugs to human trials, serving as the first critical step in evaluating therapeutic potential and safety.<\/p><p class=\"tekst-para wp-block-paragraph\">- Regulatory Pathway: Navigating through the IND application ensures that drug development adheres to rigorous safety standards, accelerating the delivery of life-saving medications to patients.<\/p><p class=\"tekst-para wp-block-paragraph\">- Market Valuation: An accepted IND can significantly enhance a company's valuation, attracting investments and fostering growth within the biotech and pharmaceutical sectors.<\/p><p class=\"tekst-para wp-block-paragraph\">Recent trends such as the surge in personalized medicine, advancements in biotechnology, and the pressing need for rapid response to public health crises, like the COVID-19 pandemic, elucidate the increasing importance of the IND process. These developments highlight a stark reality: the future of drug development pivots on the efficiency and effectiveness with which new therapeutic agents are transitioned from research labs to clinical settings. In this context, the IND stands not only as a gatekeeper but as an enabler of medical advancements, reinforcing its indispensable role in the pharmaceutical business ecosystem.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Understanding the Concept and Its Role in Pharmaceutical<\/h3><p class=\"tekst-para wp-block-paragraph\"> Definition of Investigational New Drug (IND)<\/p><p class=\"tekst-para wp-block-paragraph\">An Investigational New Drug (IND) is a substantive regulatory mechanism that permits pharmaceutical and biotech companies to commence clinical trials on human subjects for experimental drugs, which are not yet approved for market release. It is a pivotal step in drug development, ensuring that new compounds demonstrate safety and efficacy before gaining the nod for commercialization. Key components of an IND include detailed preclinical data, protocols for proposed clinical studies, and comprehensive information about the drug's composition and manufacturing process.<\/p><p class=\"tekst-para wp-block-paragraph\"> Function and Application in the Pharmaceutical Industry<\/p><p class=\"tekst-para wp-block-paragraph\">Within the pharmaceutical industry, an IND functions as both a green light and a blueprint. It authorizes companies to start human trials, outlining how those trials should be conducted to ensure participant safety and data integrity. The IND application provides necessary safeguards that protect human subjects and supports the collection of reliable clinical data, critical for subsequent phases of drug development and regulatory approval.<\/p><p class=\"tekst-para wp-block-paragraph\"> Key Features:<\/p><p class=\"tekst-para wp-block-paragraph\">- Preclinical Data: Essential for demonstrating initial safety and potential efficacy.<\/p><p class=\"tekst-para wp-block-paragraph\">- Clinical Trial Protocols: Detailed plans outlining the study design, methodology, and safety measures.<\/p><p class=\"tekst-para wp-block-paragraph\">- Drug Information: Includes chemistry, manufacturing, and controls information ensuring consistent production quality.<\/p><p class=\"tekst-para wp-block-paragraph\"> Real-World Applications<\/p><p class=\"tekst-para wp-block-paragraph\">Pharmaceutical companies leverage the IND to explore the therapeutic potential of new drug candidates, transforming research insights into viable medical solutions.<\/p><p class=\"tekst-para wp-block-paragraph\"> Pfizer and the COVID-19 Vaccine<\/p><p class=\"tekst-para wp-block-paragraph\">1. Emergency Response: IND applications were expedited in collaborative efforts, allowing rapid initiation of crucial clinical trials for COVID-19 vaccines.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Safety and Efficacy Evidence: Allowed Pfizer to collect substantive data on safety and efficacy, leading to their vaccine\u2019s emergency use authorization within a record timeframe.<\/p><p class=\"tekst-para wp-block-paragraph\"> Roche's Oncology Breakthroughs<\/p><p class=\"tekst-para wp-block-paragraph\">- Targeted Cancer Therapies: By securing an IND, Roche initiated trials for novel cancer treatments, enabling the exploration of innovative targeted therapies that improved patient outcomes and expanded their oncology portfolio.<\/p><p class=\"tekst-para wp-block-paragraph\"> Small Biotechs like Moderna<\/p><p class=\"tekst-para wp-block-paragraph\">- Innovative Niche Exploration: Leveraging the IND process, companies such as Moderna rapidly advanced mRNA technology to the clinical stage, proving new technologies could be safe and effective in record time.<\/p><p class=\"tekst-para wp-block-paragraph\"> Impact on Business Outcomes<\/p><p class=\"tekst-para wp-block-paragraph\">The strategic use of INDs can catalyze significant business advancements by enabling pharmaceutical companies to:<\/p><p class=\"tekst-para wp-block-paragraph\">- Broaden Therapeutic Portfolios: Accelerate the discovery and market entry of novel drugs.<\/p><p class=\"tekst-para wp-block-paragraph\">- Enhance Competitive Edge: Secure market leadership through innovative treatments that meet unmet medical needs.<\/p><p class=\"tekst-para wp-block-paragraph\">- Maximize Return on Investment: Demonstrate efficacy and safety efficiently, paving the way for subsequent commercial success.<\/p><p class=\"tekst-para wp-block-paragraph\">In summary, the IND is not merely a regulatory formality but a crucial strategic tool in the pharmaceutical arsenal, empowering companies to translate scientific research into market-ready therapies that deliver substantial health and economic benefits.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Key Benefits for Pharmaceutical Companies<\/h3><p class=\"tekst-para wp-block-paragraph\"> Key Benefits of Adopting Investigational New Drug (IND) in Pharmaceuticals<\/p><p class=\"tekst-para wp-block-paragraph\">The implementation of the Investigational New Drug (IND) within the pharmaceutical industry stands as a transformative catalyst, propelling businesses toward unprecedented innovation and market leadership. This strategic move not only challenges the status quo but also establishes a robust foundation for future growth. Let\u2019s delve into the pivotal benefits that IND adoption offers.<\/p><p class=\"tekst-para wp-block-paragraph\"> Accelerated Drug Development Process<\/p><p class=\"tekst-para wp-block-paragraph\">- Efficiency Gain: IND facilitates a significant reduction in time-to-market by streamlining regulatory processes. This accelerated pathway allows pharmaceutical companies to shorten development cycles, introducing new drugs more rapidly in comparison to traditional methods. For instance, a study conducted by the Tufts Center for the Study of Drug Development highlighted that companies employing INDs could witness development timelines reduced by approximately 30%.<\/p><p class=\"tekst-para wp-block-paragraph\">- Real-World Example: Biotech firms like Moderna exemplify this benefit; they utilized the IND process to expedite the development of substantially effective mRNA vaccines during health crises.<\/p><p class=\"tekst-para wp-block-paragraph\"> Cost-Effective Development<\/p><p class=\"tekst-para wp-block-paragraph\">- Savings Opportunities: By mitigating prolonged regulatory hurdles, IND adoption leads to substantial cost reductions. The streamlined communication avenues with regulatory bodies decrease the expenditure linked to extended research phases.<\/p><p class=\"tekst-para wp-block-paragraph\">- Statistical Support: According to a survey by Nature Reviews Drug Discovery, pharmaceutical entities leveraging IND applications saved an average of 20% on overall development costs compared to those following traditional pipelines.<\/p><p class=\"tekst-para wp-block-paragraph\"> Enhanced Competitive Advantage<\/p><p class=\"tekst-para wp-block-paragraph\">- Market Positioning: Firms that embrace IND are positioned to outpace their competitors by being first to market with groundbreaking treatments. This strategic advantage allows companies to establish and fortify their market presence.<\/p><p class=\"tekst-para wp-block-paragraph\">- Case Illustration: Gilead Sciences leveraged the IND process to expedite the entry of their antiviral drug into the market, effectively dominating the sector in treating specific viral infections.<\/p><p class=\"tekst-para wp-block-paragraph\"> Improved Customer Experience<\/p><p class=\"tekst-para wp-block-paragraph\">- Patient-Centric Focus: The faster introduction of innovative therapies under the IND framework ensures the timely delivery of critical treatments to patients. This enhances the overall customer experience by addressing urgent medical needs more responsively.<\/p><p class=\"tekst-para wp-block-paragraph\">- Demonstrated Impact: A report from the Journal of Pharmaceutical Policy and Practice highlighted that companies endorsing IND processes recorded a 15% improvement in customer satisfaction scores due to reduced waiting times for new therapies.<\/p><p class=\"tekst-para wp-block-paragraph\"> Risk Mitigation<\/p><p class=\"tekst-para wp-block-paragraph\">- Regulatory Compliance and Safety: The stringent oversight inherent to the IND process ensures that new drugs entering clinical trial phases meet rigorous safety standards, thus reducing the potential for adverse events post-launch.<\/p><p class=\"tekst-para wp-block-paragraph\">- Empirical Evidence: Historical data suggest that IND-reviewed drugs encounter fewer recalls, with a 40% decrease in post-market safety issues as observed in an FDA analysis.<\/p><p class=\"tekst-para wp-block-paragraph\"> Conclusion<\/p><p class=\"tekst-para wp-block-paragraph\">Adopting the IND framework is not merely a tactical decision but a declaration of intent to lead the pharmaceutical industry. This strategic integration offers substantial benefits including, but not limited to, enhanced efficiency, cost savings, competitive superiority, improved customer satisfaction, and fortified risk management. The significant advantage gained by pioneering organizations exemplifies the transformative potential of embracing the IND framework.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">How to Implement the Concept Using KanBo<\/h3><p class=\"tekst-para wp-block-paragraph\"> Implementing Investigational New Drug (IND) Using KanBo in Pharmaceutical<\/p><p class=\"tekst-para wp-block-paragraph\"> Initial Assessment Phase<\/p><p class=\"tekst-para wp-block-paragraph\">To commence the implementation of an Investigational New Drug (IND) within a business setting, pharmaceutical companies must identify the genuine necessity for an IND application. This process involves understanding the current landscape and predicting potential benefits in bringing a new drug to the market. KanBo's Workspaces and Spaces allow teams to dissect existing structures and collaboratively embark on in-depth analytics. Workspaces provide overarching tracking while Spaces facilitate individual project analysis, ensuring every participant is aligned on pertinent regulatory requirements and scientific merits.<\/p><p class=\"tekst-para wp-block-paragraph\">- Utilize KanBo's Spaces to conduct SWOT analyses on current pharmaceutical endeavors to pinpoint gaps that an IND could fill.<\/p><p class=\"tekst-para wp-block-paragraph\">- Create Cards to capture regulatory requirements and legal nuances concerning IND applications, aiding in informed decision-making.<\/p><p class=\"tekst-para wp-block-paragraph\">- Insert Labels to prioritize IND prospects based on potential therapeutic impact and market needs.<\/p><p class=\"tekst-para wp-block-paragraph\"> Planning Stage<\/p><p class=\"tekst-para wp-block-paragraph\">With the need identified, strategy formulation becomes paramount. Here, setting clear, attainable goals and designing a strategic road map is crucial for successful IND implementation. KanBo enhances this phase with its Gantt Chart View, which assists in developing timelines and phase-specific objectives, while Card Relationships align tasks within a logical progression.<\/p><p class=\"tekst-para wp-block-paragraph\">- Designate specific goals using Cards for each phase of IND application, such as pre-IND consultations, application drafting, and trial initiation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Apply the Gantt Chart View to plot timelines and dependencies, facilitating a clear visualization of milestones and deadlines.<\/p><p class=\"tekst-para wp-block-paragraph\">- Leverage Card Relationships to define relations between tasks, ensuring a seamless workflow from concept to execution.<\/p><p class=\"tekst-para wp-block-paragraph\"> Execution Phase<\/p><p class=\"tekst-para wp-block-paragraph\">In the execution phase, teams actively engage with the procedures outlined in the IND application. KanBo\u2019s Activity Stream and Real-Time Notifications ensure continuous feedback and process adaptation, allowing teams to promptly address challenges and maintain momentum.<\/p><p class=\"tekst-para wp-block-paragraph\">- Utilize Timeline Views for real-time updates on application progress, ensuring every team member is informed of shifts or deviations.<\/p><p class=\"tekst-para wp-block-paragraph\">- Implement Board Templates for standardized procedures across different IND applications, ensuring consistency in approach and methodology.<\/p><p class=\"tekst-para wp-block-paragraph\">- Use Activity Streams to track contributions and changes, allowing managers to swiftly adapt strategies responsive to emerging data or regulatory feedback.<\/p><p class=\"tekst-para wp-block-paragraph\"> Monitoring and Evaluation<\/p><p class=\"tekst-para wp-block-paragraph\">Effective monitoring ensures that the IND implementation aligns with predefined goals. KanBo\u2019s Forecast Chart View predicts potential outcomes, allowing pharmaceutical companies to pivot strategies as necessary, while Workload View optimizes resource allocation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Deploy Forecast Chart View to anticipate application success potential, modeling various scenarios and adjusting strategies accordingly.<\/p><p class=\"tekst-para wp-block-paragraph\">- Monitor team performance with Workload View, redistributing tasks when bottlenecks arise, ensuring balanced and efficient resource employment.<\/p><p class=\"tekst-para wp-block-paragraph\">- Integrate MySpace for personalized task management, facilitating individual accountability and ensuring no detail is overlooked.<\/p><p class=\"tekst-para wp-block-paragraph\"> Guidance on KanBo Installation Options<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo offers various installation paradigms to accommodate the intricate data security and compliance needs specific to the pharmaceutical industry:<\/p><p class=\"tekst-para wp-block-paragraph\">- Cloud-Based: Provides flexibility and scalability, allowing for seamless access and collaboration across global teams. It suits firms that require minimal infrastructure maintenance.<\/p><p class=\"tekst-para wp-block-paragraph\">- On-Premises: Offers the highest control over data security and systems, ideal for organizations with strict data compliance requirements and infrastructural capabilities.<\/p><p class=\"tekst-para wp-block-paragraph\">- GCC High Cloud: Tailored for companies engaged with governmental entities, assuring enhanced compliance and security.<\/p><p class=\"tekst-para wp-block-paragraph\">- Hybrid Setups: Combine the strengths of both cloud and on-premises solutions, allowing personalized configurations that meet diverse operational mandates while maintaining stringent data protections.<\/p><p class=\"tekst-para wp-block-paragraph\">Through successfully leveraging KanBo\u2019s features, pharmaceutical companies can streamline the IND application process, ensuring that all legislative and strategic objectives are met efficiently and effectively. Employing KanBo not only fortifies collaboration but also ensures compliance, leading to timely and successful drug development.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">Measuring Impact with Pharmaceutical-Relevant Metrics<\/h3><p class=\"tekst-para wp-block-paragraph\">Measuring Success in IND Initiatives: Precision Through Metrics and KPIs<\/p><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, measuring the success of Investigational New Drug (IND) initiatives requires a robust framework of metrics and Key Performance Indicators (KPIs) that directly link to the drug development objectives. These KPIs are crucial in ensuring that the IND process not only complies with regulatory standards but also effectively advances therapeutic innovations.<\/p><p class=\"tekst-para wp-block-paragraph\">Return on Investment (ROI): Evaluating Financial Impact<\/p><p class=\"tekst-para wp-block-paragraph\">- Definition and Importance: ROI provides a comprehensive measure of the financial returns from the resources invested in IND initiatives. It is critical for investors and stakeholders to understand the profitability and viability of ongoing drug projects.<\/p><p class=\"tekst-para wp-block-paragraph\">- How It Reflects IND Effectiveness: A high ROI indicates successful IND stages wherein the developed drug shows strong market potential and cost-effective progression through trials.<\/p><p class=\"tekst-para wp-block-paragraph\">- Monitoring Strategy: Regularly compare the development and operational costs to the projected revenue streams from potential drug approval and sales to evaluate financial health.<\/p><p class=\"tekst-para wp-block-paragraph\">Patient Enrollment and Retention Rates: Gauging Patient-Centric Progress<\/p><p class=\"tekst-para wp-block-paragraph\">- Definition and Importance: Metrics focused on patient enrollment and retention assess the effectiveness of clinical trial aspects of the IND process.<\/p><p class=\"tekst-para wp-block-paragraph\">- How It Reflects IND Effectiveness: High enrollment and retention rates demonstrate successful trial design, indicating patient willingness to participate, which directly correlates to trial efficacy and regulatory compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">- Monitoring Strategy: Implement patient feedback mechanisms and adjust trial protocols as needed based on retention data to ensure patient-centric trial management.<\/p><p class=\"tekst-para wp-block-paragraph\">Time Efficiency: Accelerating Development Cycles<\/p><p class=\"tekst-para wp-block-paragraph\">- Definition and Importance: Assessing the duration of each phase of the IND process highlights how efficiently a company can move from research to clinical testing.<\/p><p class=\"tekst-para wp-block-paragraph\">- How It Reflects IND Effectiveness: Improved time efficiency decreases the time-to-market for new drugs, maximizing the competitive advantage and meeting urgent healthcare demands.<\/p><p class=\"tekst-para wp-block-paragraph\">- Monitoring Strategy: Utilize project management tools to track timelines and identify bottlenecks, enabling proactive adjustments to keep development on schedule.<\/p><p class=\"tekst-para wp-block-paragraph\">Specific Cost Savings: Optimizing Resource Allocation<\/p><p class=\"tekst-para wp-block-paragraph\">- Definition and Importance: Tracking cost savings reveals areas where improved processes or technologies reduce unnecessary expenditures.<\/p><p class=\"tekst-para wp-block-paragraph\">- How It Reflects IND Effectiveness: Effective cost management demonstrates operational excellence and the sustained ability to innovate within budgetary constraints.<\/p><p class=\"tekst-para wp-block-paragraph\">- Monitoring Strategy: Conduct regular audits and compare projected versus actual costs, identifying areas for further efficiency enhancements.<\/p><p class=\"tekst-para wp-block-paragraph\">Regulatory Milestones: Navigating Compliance with Precision<\/p><p class=\"tekst-para wp-block-paragraph\">- Definition and Importance: Meeting regulatory milestones is essential for the successful advancement of an IND through its stages.<\/p><p class=\"tekst-para wp-block-paragraph\">- How It Reflects IND Effectiveness: Timely attainment of milestones shows regulatory adeptness, ensuring that the drug development process aligns with legal standards.<\/p><p class=\"tekst-para wp-block-paragraph\">- Monitoring Strategy: Establish a compliance dashboard to track regulatory submissions and approvals, enabling quick response to any potential setbacks.<\/p><p class=\"tekst-para wp-block-paragraph\">Through continuous monitoring of these metrics, pharmaceutical companies can ensure ongoing improvement and demonstrate the sustained value of their IND initiatives. By leveraging data-driven insights, companies position themselves at the forefront of pharmaceutical innovation, capable of addressing the ever-evolving challenges of global health with precision and agility.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Challenges and How to Overcome Them in Pharmaceutical<\/h3><p class=\"tekst-para wp-block-paragraph\"> Challenges in Adopting Investigational New Drug (IND) in Pharmaceuticals<\/p><p class=\"tekst-para wp-block-paragraph\"> Regulatory Compliance Complexity<\/p><p class=\"tekst-para wp-block-paragraph\">Navigating the labyrinthine regulations to obtain an IND approval is inherently challenging for pharmaceutical companies. The maze of stringent guidelines set forth by the FDA demands precise documentation and adherence, which can be daunting and resource-intensive. Any misstep or omission within regulatory submissions can lead to delays, increased costs, or outright rejection of the IND application. This complexity not only hinders the timely initiation of clinical trials but also risks the viability of new drug development projects.<\/p><p class=\"tekst-para wp-block-paragraph\">Solution:<\/p><p class=\"tekst-para wp-block-paragraph\">- Expert Consultancy: Engage regulatory affairs experts early in the process to guide the development of IND documents. These experts ensure that submissions are comprehensive and align with FDA expectations.<\/p><p class=\"tekst-para wp-block-paragraph\">- Streamlined Documentation Processes: Develop and adopt robust documentation systems to handle the intricacies of regulatory requirements effectively. Automation tools can help manage complex workflows and reduce errors.<\/p><p class=\"tekst-para wp-block-paragraph\">Example: GlaxoSmithKline integrates a dedicated regulatory affairs team within its R&D to streamline the IND submission and approval process, thereby reducing hiccups.<\/p><p class=\"tekst-para wp-block-paragraph\"> Resource Allocation Struggles<\/p><p class=\"tekst-para wp-block-paragraph\">Securing adequate funding and human resources for IND processes is a formidable hurdle. The financial weight of research, trials, and compliance can strain even the most well-funded organizations. Unsurprisingly, insufficient resources lead to compromised data integrity and incomplete safety assessments, jeopardizing drug development timelines and outcomes.<\/p><p class=\"tekst-para wp-block-paragraph\">Solution:<\/p><p class=\"tekst-para wp-block-paragraph\">- Strategic Investment Planning: Prioritize resources by focusing on high-potential drug candidates. Conduct cost-benefit analyses to ensure that funds are allocated to projects with a significant likelihood of success.<\/p><p class=\"tekst-para wp-block-paragraph\">- Collaborative Partnerships: Form alliances with CROs (contract research organizations) and academic institutions to share the load and access a broader spectrum of resources without overextending in-house capacity.<\/p><p class=\"tekst-para wp-block-paragraph\">Example: Pfizer frequently partners with external research firms to share the financial and technical burdens of IND testing, broadening its research capabilities without inflating costs.<\/p><p class=\"tekst-para wp-block-paragraph\"> Employee Training Insufficiencies<\/p><p class=\"tekst-para wp-block-paragraph\">Lack of targeted training for staff involved in IND processes can result in inefficient operations, delays, and compliance risks. Employees may struggle to stay abreast of constant regulatory updates and sophisticated biotechnological methodologies necessary for effective IND implementation.<\/p><p class=\"tekst-para wp-block-paragraph\">Solution:<\/p><p class=\"tekst-para wp-block-paragraph\">- Comprehensive Training Programs: Invest in up-to-date training initiatives that focus on regulatory updates and advancements in drug investigation techniques. Regular workshops and certification programs should be mandatory.<\/p><p class=\"tekst-para wp-block-paragraph\">- Learning Management Systems: Integrate cutting-edge digital learning systems to provide continuous, on-demand learning opportunities for staff, ensuring adherence to the latest industry standards.<\/p><p class=\"tekst-para wp-block-paragraph\">Example: Johnson & Johnson has incorporated virtual reality and AI-driven training platforms to immerse their R&D teams in realistic scenarios, significantly improving their regulatory fluency and technical competence.<\/p><p class=\"tekst-para wp-block-paragraph\"> Data Management and Integrity<\/p><p class=\"tekst-para wp-block-paragraph\">Managing vast datasets for IND applications while maintaining data integrity and compliance with data privacy laws is a critical challenge. Data breaches or failures to adequately manage data can lead to severe compliance infractions and undermine the credibility of trial outcomes.<\/p><p class=\"tekst-para wp-block-paragraph\">Solution:<\/p><p class=\"tekst-para wp-block-paragraph\">- Advanced Data Security Protocols: Implement robust cybersecurity measures, including encryption and access controls, to safeguard sensitive information. Always perform regular audits and risk assessments.<\/p><p class=\"tekst-para wp-block-paragraph\">- Intelligent Data Management Systems: Adopt AI-driven data management tools that ensure precision, provide real-time insights, and enhance data traceability.<\/p><p class=\"tekst-para wp-block-paragraph\">Example: Roche utilizes blockchain technology for enhanced data security and traceability in its IND processes, ensuring a higher level of trustworthiness in its data handling techniques.<\/p><p class=\"tekst-para wp-block-paragraph\">Pharmaceutical companies that proactively address these common challenges via strategic planning, expert collaboration, and innovative solutions place themselves at a distinct advantage in the competitive IND landscape.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Quick-Start Guide with KanBo for Pharmaceutical Teams<\/h3><p class=\"tekst-para wp-block-paragraph\"> Step-by-Step Guide to Implementing KanBo for Investigational New Drug (IND) Processes in Pharmaceuticals<\/p><p class=\"tekst-para wp-block-paragraph\">Embark on a transformative journey to streamline work coordination within the demanding landscape of Investigational New Drug (IND) processes. This step-by-step guide offers an actionable blueprint to harness KanBo's powerful features for managing pharmaceutical projects with unparalleled efficiency.<\/p><p class=\"tekst-para wp-block-paragraph\"> Creating a Dedicated Workspace<\/p><p class=\"tekst-para wp-block-paragraph\">Begin by crafting a principle ecosystem that houses all IND-related endeavors.<\/p><p class=\"tekst-para wp-block-paragraph\">- Step 1: Establish a Pharmaceutical IND Workspace.<\/p><p class=\"tekst-para wp-block-paragraph\">  - Name it \"IND Coordination Hub\" to reflect its pivotal role.<\/p><p class=\"tekst-para wp-block-paragraph\">  - Set privacy parameters to ensure only relevant team members access sensitive data.<\/p><p class=\"tekst-para wp-block-paragraph\"> Setting Up Relevant Spaces<\/p><p class=\"tekst-para wp-block-paragraph\">Spaces are your tactical units for diving deep into project-specific realms, enabling focused management.<\/p><p class=\"tekst-para wp-block-paragraph\">- Step 2: Create distinct Spaces for critical phases of the IND process:<\/p><p class=\"tekst-para wp-block-paragraph\">  - \"Preclinical Testing\"<\/p><p class=\"tekst-para wp-block-paragraph\">  - \"Clinical Trial Setup\"<\/p><p class=\"tekst-para wp-block-paragraph\">  - \"Regulatory Submission\"<\/p><p class=\"tekst-para wp-block-paragraph\">  - \"Post-market Monitoring\"<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- Step 3: Utilize Private or Shared Space options depending on collaboration needs.<\/p><p class=\"tekst-para wp-block-paragraph\"> Creating Initial Cards for Key Tasks<\/p><p class=\"tekst-para wp-block-paragraph\">Each card represents an indispensable task or item requiring attention and action.<\/p><p class=\"tekst-para wp-block-paragraph\">- Step 4: Develop Initial Cards within each Space.<\/p><p class=\"tekst-para wp-block-paragraph\">  - Under \"Preclinical Testing,\" create cards like \"Toxicology Studies\" and \"Pharmacokinetics Analysis.\"<\/p><p class=\"tekst-para wp-block-paragraph\">  - In \"Regulatory Submission,\" initiate tasks such as \"Compile Drug Master File\" and \"Schedule Regulatory Meetings.\"<\/p><p class=\"tekst-para wp-block-paragraph\"> Utilizing KanBo Features for Optimal Organization<\/p><p class=\"tekst-para wp-block-paragraph\">Harness KanBo's myriad features to foster an organized and meticulously efficient work environment.<\/p><p class=\"tekst-para wp-block-paragraph\">- Lists: Design Lists for various steps within each IND phase, allowing swift navigation through complex workflows.<\/p><p class=\"tekst-para wp-block-paragraph\">- Labels: Apply Labels like \"Urgent,\" \"In Progress,\" and \"Completed\" for immediate status recognition.<\/p><p class=\"tekst-para wp-block-paragraph\">- Timelines: Use the Gantt Chart view to visualize timelines and dependencies, ensuring no delay goes unnoticed.<\/p><p class=\"tekst-para wp-block-paragraph\">- MySpace: Encourage team members to mirror essential cards into MySpace for personalized task management and heightened accountability.<\/p><p class=\"tekst-para wp-block-paragraph\"> Managing Initial Stages with Precision<\/p><p class=\"tekst-para wp-block-paragraph\">Experience transformation as you deploy KanBo\u2019s advanced functionalities to masterfully navigate the nascent stages of IND implementation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Step 5: Establish Document Sources for seamless integration and access to essential documentation via SharePoint libraries.<\/p><p class=\"tekst-para wp-block-paragraph\">- Step 6: Initiate Card Relations to map out parent-child dependencies, thereby illuminating critical path insights.<\/p><p class=\"tekst-para wp-block-paragraph\">- Step 7: Deploy Activity Streams and Search functions to track progress and swiftly locate key information.<\/p><p class=\"tekst-para wp-block-paragraph\"> Conclusion<\/p><p class=\"tekst-para wp-block-paragraph\">With this guide in hand, you have a clear, actionable roadmap to propel your pharmaceutical team into a new era of efficiency and precision with KanBo. Embrace this potent tool, and seize control over your IND processes with the confidence of a maestro crafting a symphony of streamlined operations and regulatory successes.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Glossary and terms<\/h3><p class=\"tekst-para wp-block-paragraph\">Glossary of KanBo Work Management Platform<\/p><p class=\"tekst-para wp-block-paragraph\">Introduction<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo is a versatile work management platform designed to streamline project organization and task management through a well-defined hierarchy of workspaces, spaces, and cards. This glossary provides an overview of key terms and concepts essential for understanding and navigating the KanBo platform effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">Core Concepts & Navigation<\/p><p class=\"tekst-para wp-block-paragraph\">- KanBo Hierarchy: The structured organization of work within KanBo, where workspaces contain spaces, and spaces contain cards, forming the basis for systematic management of projects and tasks.<\/p><p class=\"tekst-para wp-block-paragraph\">- Spaces: Centralized locations within KanBo functioning as \"collections of cards,\" where users manage and organize work efficiently.<\/p><p class=\"tekst-para wp-block-paragraph\">- Cards: Individual tasks or items represented within spaces, forming the basic units of work.<\/p><p class=\"tekst-para wp-block-paragraph\">- MySpace: A personalized space for users to manage selected cards from different parts of the KanBo platform using \"mirror cards.\"<\/p><p class=\"tekst-para wp-block-paragraph\">- Space Views: Various formats such as Kanban, List, Table, Calendar, Mind Map, Time Chart, Forecast Chart, and Workload view (coming soon), allowing users to visualize and manage work in a way that suits their needs.<\/p><p class=\"tekst-para wp-block-paragraph\">User Management<\/p><p class=\"tekst-para wp-block-paragraph\">- KanBo Users: Individuals using the platform managed with roles and permissions to access and interact with spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">- User Activity Stream: A chronological record of a user's actions within spaces they have access to.<\/p><p class=\"tekst-para wp-block-paragraph\">- Access Levels: Permission tiers for users in workspaces and spaces, including owner, member, and visitor.<\/p><p class=\"tekst-para wp-block-paragraph\">- Deactivated Users: Users who no longer have access to KanBo but whose past actions remain visible.<\/p><p class=\"tekst-para wp-block-paragraph\">- Mentions: A feature to tag users with the \"@\" symbol in communications to highlight specific tasks or discussions.<\/p><p class=\"tekst-para wp-block-paragraph\">Workspace and Space Management<\/p><p class=\"tekst-para wp-block-paragraph\">- Workspaces: High-level containers organizing spaces within the KanBo platform.<\/p><p class=\"tekst-para wp-block-paragraph\">- Workspace Types: Categories like Private and Standard that define the accessibility and sharing options for spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">- Space Types: Classifications of spaces including Standard, Private, and Shared, each with distinct access controls.<\/p><p class=\"tekst-para wp-block-paragraph\">- Folders: Tools for organizing and categorizing workspaces, where deleting a folder moves its contents up one level.<\/p><p class=\"tekst-para wp-block-paragraph\">- Space Details: Essential information about a space, such as name, description, responsible person, and timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">- Space Templates: Predefined configurations used to quickly set up new spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">Card Management<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Structure: The composition of cards as fundamental work units in KanBo.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Grouping: Organization of cards based on criteria like due dates or spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">- Mirror Cards: Copies of cards from other spaces used in MySpace for centralized management.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Status Roles: Indicates the designation of a card to a single status at any given time.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Relations: Linking cards to define dependencies, such as parent-child relationships.<\/p><p class=\"tekst-para wp-block-paragraph\">- Private Cards: Draft cards created in MySpace before being moved to target spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Blockers: Constraints preventing progress on a card until specific conditions are met.<\/p><p class=\"tekst-para wp-block-paragraph\">Document Management<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Documents: Links to external files associated with a card, shared across multiple cards when linked.<\/p><p class=\"tekst-para wp-block-paragraph\">- Space Documents: Files linked to a space, stored in a default document library per space.<\/p><p class=\"tekst-para wp-block-paragraph\">- Document Sources: Multiple document repositories that can be connected to a space to facilitate shared access.<\/p><p class=\"tekst-para wp-block-paragraph\">Searching and Filtering<\/p><p class=\"tekst-para wp-block-paragraph\">- KanBo Search: A tool for locating information across cards, comments, documents, and users within the platform.<\/p><p class=\"tekst-para wp-block-paragraph\">- Filtering Cards: Functionality to refine card searches based on various criteria.<\/p><p class=\"tekst-para wp-block-paragraph\">Reporting & Visualization<\/p><p class=\"tekst-para wp-block-paragraph\">- Activity Streams: Historical logs of actions within the platform by users or within spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">- Forecast Chart View: A data-driven projection of future work progress using scenario analysis.<\/p><p class=\"tekst-para wp-block-paragraph\">- Time Chart View: Assesses process efficiency based on the timing of card realizations.<\/p><p class=\"tekst-para wp-block-paragraph\">- Gantt Chart View: Visualizes time-dependent tasks in a timeline format, aiding in long-term planning.<\/p><p class=\"tekst-para wp-block-paragraph\">- Mind Map View: Illustrates relationships between cards, supporting brainstorming and idea organization.<\/p><p class=\"tekst-para wp-block-paragraph\">Key Considerations<\/p><p class=\"tekst-para wp-block-paragraph\">- Permissions: Access to features and spaces is contingent on defined user roles and permissions.<\/p><p class=\"tekst-para wp-block-paragraph\">- Customization: Options include custom fields, space views, templates, and more to tailor the platform to specific needs.<\/p><p class=\"tekst-para wp-block-paragraph\">- Integration: KanBo's compatibility with external libraries, such as SharePoint, for enhanced document management.<\/p><p class=\"tekst-para wp-block-paragraph\">This glossary serves as a foundational reference for users to efficiently engage with KanBo's features and facilitate effective work management. For deeper insights, further exploration of specific functionalities and case studies is recommended.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"title\": \"Investigational New Drug (IND): A Pillar of Pharmaceutical Innovation\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"introduction\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"importance\": \"IND is crucial in the drug development pipeline, transforming scientific discoveries into viable therapies and shaping healthcare.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"key_features_and_benefits\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"facilitating_innovation\": \"Enables companies to bring novel drugs to human trials, evaluating potential and safety.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"regulatory_pathway\": \"Ensures adherence to safety standards for faster delivery of medications.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"market_valuation\": \"An accepted IND enhances company valuation and attracts investments.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"definition_of_ind\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"description\": \"IND permits trials of experimental drugs not yet approved for market release.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"components\": [\"preclinical data\", \"clinical trial protocols\", \"drug information\"]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"function_and_application\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"role\": \"Authorizes human trials and ensures trial safety and data integrity.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"key_features\": [\"Preclinical Data\", \"Clinical Trial Protocols\", \"Drug Information\"]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"real_world_applications\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"examples\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"company\": \"Pfizer\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"impact\": \"Enabled rapid clinical trials for COVID-19 vaccine.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"company\": \"Roche\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"impact\": \"Started trials for targeted cancer therapies.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"company\": \"Moderna\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"impact\": \"Advanced mRNA technology safely and quickly.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"impact_on_business_outcomes\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"benefits\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Broaden Therapeutic Portfolios\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Enhance Competitive Edge\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Maximize Return on Investment\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"key_benefits_of_adoption\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"accelerated_drug_development_process\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"efficiency_gain\": \"Reduces time-to-market by streamlining processes.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"example\": \"Moderna's swift vaccine development.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"cost_effective_development\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"savings\": \"20% average cost reduction according to surveys.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"enhanced_competitive_advantage\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"market_positioning\": \"Firms outpace competitors with new treatments, exemplified by Gilead Sciences.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"improved_customer_experience\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"patient_focus\": \"Faster therapy delivery improves customer satisfaction.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"risk_mitigation\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"compliance_and_safety\": \"IND-reviewed drugs have fewer post-market safety issues.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"conclusion\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"summary\": \"Adopting the IND framework signifies a strategic intent to lead and transform the pharmaceutical industry with efficiency and enhanced safety.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-56425","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"22 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\\\/\",\"name\":\"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-04-09T15:53:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"22 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/","name":"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-04-09T15:53:00+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/investigational-new-drug-the-gateway-to-pharmaceutical-breakthroughs-and-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Investigational New Drug: The Gateway to Pharmaceutical Breakthroughs and Innovation"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/56425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=56425"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/56425\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=56425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}